Quidel | QDEL - 销售收入

金融业

USD

USD 5.77B

现金及等价物

USD 169.8M

USD 448.8M

USD 1.45B

USD 966.1M

USD 2.84B

USD -37.3M

USD 153.3M

6.6K

EPS每股收益

USD 0.46

股本和储备

USD 1.92B

USD 274.8M

债务利息支出

USD 5.68B

USD -10.78

USD 2.47B

USD 803.5M

USD -733M

USD 760.9M

USD -37.3M

普通股股本

USD 67.9M

2.03

USD -756.9M

USD 724M

销售和管理费用

USD 194.4M

USD 577.6M

贸易债权人

USD 279.4M

应收帐款人

USD 417M

	销售	更改		日
Abbott	USD 11.16B		300M	2026-03
Agilent	USD 1.8B		63M	2025-12
Avanos Medical	USD 180.9M		3.1M	2025-12
Becton, Dickinson and Co.	USD 5.3B		600M	2025-12
Bruker	USD 977.2M		116.7M	2025-12
Cerus	USD 50.81M		4.79M	2024-12
Charles River Laboratories	USD 994.2M		5.8M	2025-12
Danaher	USD 5.95B		890M	2026-03
Haemonetics	USD 338.97M		11.97M	2025-12
Illumina	USD 1.16B		80M	2025-12
IQVIA Holdings	USD 4.36B		260M	2025-12
Merit Medical Systems	USD 393.9M		9.7M	2025-12
Mettler Toledo International	USD 1.13B		100M	2025-12
Myriad Genetics	USD 209.8M		4.1M	2025-12
Neogen	USD 211.2M		13.49M	2025-12
OraSure Technologies	USD 26.76M		322K	2025-12
Pacific Biosciences Of California	USD 44.64M		6.2M	2025-12
Quidel	USD 724M		24M	2025-12
Revvity	USD 772.06M		73.06M	2025-12
STAAR Surgical	USD 239.4M		144.7M	2025-12
Thermo Fisher Scientific	USD 11.01B		1.2B	2026-03
Waters	USD 932M		132M	2025-12